Hjem › Alopesi areata › Ohio
Kliniske studier for Alopesi areata i Ohio
6 studier for Alopesi areata søker deltakere på steder i Ohio.
Byer i Ohio
Offisiell studietekst (engelsk)
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
- Dermatologists of Southwestern Ohio (DSWO) /ID# 282818, Fairborn
RekruttererFase 3
Alder 6 til 17 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07772492A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- Bexley Dermatology Research, Bexley
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT06873945HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
- The Ohio State University Wexner Medical Center, Columbus
RekruttererFase 1
Alder 18 til 70 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07049328A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
- Bexley Dermatology Research, Bexley
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 10. sep. 2026 · NCT07733765A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
- Cleveland Clinic - Cleveland /ID# 258113, Cleveland
- Dermatologists of Southwest Ohio, Inc /ID# 260116, Mason
RekruttererFase 3
Alder 12 til 63 · Alle kjønn · Oppdatert 3. aug. 2026 · NCT06012240Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- Dermatologists Of Southwest Ohio, Mason
RekruttererFase 3
Alder 12 til 17 · Alle kjønn · Oppdatert 28. jan. 2026 · NCT07133308Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.